Publication

Clinical Trials Acronyms

Scattered wooden alphabet letters on blue background

This resource provides a curated list of commonly used acronyms and abbreviations in clinical trials and clinical research.

Who is this for?

Trial teams, researchers, health consumers, trial participants and support staff who need support navigating the language of clinical trials.

Key Takeaways

  • Understand acronyms used across all clinical trial domains
  • Quickly familiarise yourself with essential terminology
  • Enable clearer communication and documentation in clinical trial settings

This resource is designed to decode the jargon and support anyone working in clinical trials to understand the complex terminology. Having a clearer understanding, improves communication across trial teams and stakeholders.

ADaM – Analysis Data Model (statistics standard)

ADE – Adverse Device Effect

ADR – Adverse Drug Reaction

AE – Adverse Event

AI – Associate Investigator

ALCOA – Attributable, Legible, Contemporaneous, Original, Accurate

ANZCTR – Australia and New Zealand Clinical Trials Registry

AR – Adverse Reaction

ARTG – Australian Register of Therapeutic Goods

ASR – Annual Safety Report

CAP – Consumer Advisory Panel

CAPA – Corrective and Preventative Action

CDA – Confidentiality Disclosure Agreement

CDASH – Clinical Data Acquisition Standards Harmonisation (statistics standard)

CDISC – The Clinical Data Interchange Standards Consortium

CI – Chief-Investigator

CMO – Contract Manufacturing Organisation

COA – Clinical Outcome Assessments

Co-I – Co-Investigator

COV – Close-Out Visit

CPI – Coordinating Principal Investigator

CRA – Clinical Research Associate

CRC – Clinical Research Coordinator

CRF – Case Report Form

CRO – Contract Research Organisation

CSO – Contract Safety Organisation

CRN – Clinical Research Nurse

CSR – Clinical Study Report

CT – Clinical Trial

CTA – Clinical Trial Approval (scheme) – previously Clinical Trial Exemption (CTX)

CTAC(P) – Clinical Trials Advisory Committee (or Panel)

CTC – Clinical Trial Co-ordinator

CTCAE – Common Terminology Criteria for Adverse Events

CTMS – Clinical Trial Management System

CTN – Clinical Trial Notification (Scheme)

DAEN – Database of Adverse Event Notifications – medicines or devices

DCF – Data Correction Form

DCT – Decentralised Clinical Trial

DLT – Dose Limiting Toxicity

DM – Data Manager

DMP – Data Management Plan

DOA – Delegation of Authority

DSMC(B) – Data Safety Monitoring Committee (or Board)

DSUR – Development Safety Update Report

EC – Ethics Committee

eCOA – Electronic Clinical Outcome Assessments

eCRF – Electronic Case Report Form

eSource – Electronic Source Data

ED – Essential Documents

EDC – Electronic Data Capture

EMA – European Medicines Agency

EMR – Electronic Medical Record

EOS – End of Study

ePRO – Electronic Patient-Reported Outcomes

eTMF – Electronic Trial Master File

EU – European Union

EMR – Electronic Medical Records

FDA – Food and Drug Administration

FIH – First in Human

FPI – First Patient In (recruited to a trial)

FPFV – First Patient First Visit

GCDMP – Good Clinical Data Management Practice

GCP – Good Clinical Practice

GDP – Good Documentation Practice

GDRP – General Data Protection Regulation

GLNR – Greater than Low Risk

GLP – Good Laboratory Practice

GMO – Genetically Modified Organism

GMP – Good Manufacturing Practice

GVP – Good Pharmacovigilance Practice

HCP – Health Care Provider

HIPAA – Health Insurance Portability and Accountability Act

HREA – Human Research Ethics Application

HREC – Human Research Ethics Committee

IB – Investigator’s Brochure

ICF – Informed Consent Form

ICH – International Conference on Harmonization

IDMC – Independent Data Monitoring Committee

IIT – Investigator Initiated Trials

IP – Investigational Product

IMD – Investigational Medicinal Device

IMP – Investigational Medicinal Product

IMV – Interim Monitoring Visit

IND – Investigational New Drug

IVRS – Interactive Voice Recognition System

IRB – Institutional Review Board

ISF – Investigator Site File

LHD – Local Health District

LNR – Low and Negligible Risk

LOI – Letter of Intent

LPLV – Last Patient Last Visit

MD – Medical Device

MMP – Medical Monitoring Plan

MP – Monitoring Plan

MTA – Material Transfer Agreement

NCTGF – National Clinical Trials Governance Framework

NDA – New Drug Application

NIH – National Institutes of Health (US)

NMA – National Mutual Acceptance

NHMRC – National Health and Medical Research Council

OGTR – Office of Gene Technology Regulator

PHA – Public Health Act

PHI – Protected Health Information

PHO – Public Health Organisation

PI – Principal Investigator

PICF – Patient Information Sheet and Consent Form

PIS – Patient Information Sheet

PK – Pharmacokinetic

PD – Pharmacodynamic

PSQV – Pre-Study Qualification Visit

PV – Pharmacovigilance (Safety)

QA – Quality Assurance

QC – Quality Control

QMS – Quality Management System

QOL – Quality of Life

QRM – Quality Risk Management

RA – Research Associate

RCA – Root Cause Analysis

RCT – Randomised controlled trial

RBM – Risk Based Monitoring

REGIS – Research Ethics and Governance Information System (NSW & ACT)

RGO – Research Governance Office

RWD(E) – Real World Data (or Evidence)

SADE – Serious Adverse Device Effect

SAE – Serious Adverse Effect

SAR – Serious Adverse Reaction

SaMD – Software as a Medical Device

SC – Study Coordinator

SDTM – Study Data Tabulation Model (statistics standard)

SDV – Source Document Verification

SIV – Site Initiation Visit

SMP – Safety Monitoring Plan

SOA – Schedule of Assessments

SOC – Standard of Care

SOP – Standard Operating Procedure

SQV – Site Qualification Visit

Sub-I – Sub Investigator

SSI – Significant Safety Issue

SSU – Study Start Up

SSV – Site Selection Visit

SMF – Site Master File

SOP – Standard Operating Procedure

SSA (STE) – Site Specific Assessment (Research Governance application)

SUSAR – Serious Unexpected Suspected Adverse Reaction

TGA – Therapeutic Goods Administration

TLF – Tables, listings and figures (used in clinical study reports)

TMF – Trial Master File

Tx – Treatment

USADE – Unanticipated Serious Adverse Device Effect

UADR – Unexpected Adverse Drug Reaction

USM – Urgent Safety Measure

WHO – World Health Organization